Filippos Kesisoglou

发表

Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms

Talia Flanagan, Andre Hermans, Andreas M. Abend, 2017, The AAPS Journal.

Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products

Talia Flanagan, Filippos Kesisoglou, Arzu Selen, 2020, The AAPS Journal.

Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report

Amitava Mitra, Nikunjkumar Patel, Filippos Kesisoglou, 2019, The AAPS Journal.

Meeting Report: Applied Biopharmaceutics and Quality by Design for Dissolution/Release Specification Setting: Product Quality for Patient Benefit

Anette Müllertz, Filippos Kesisoglou, Yi Tsong, 2010, The AAPS Journal.

Current status and future opportunities for incorporation of dissolution data in pbpk modeling for pharmaceutical development and regulatory applications: orbito consortium commentary.

Filippos Kesisoglou, Tycho Heimbach, Xavier Pepin, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The Role of Physiologically Based Oral Absorption Modelling in Formulation Development Under a Quality by Design Paradigm.

Filippos Kesisoglou, 2017, Journal of pharmaceutical sciences.

Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report

Filippos Kesisoglou, Tycho Heimbach, Sandra Suarez-Sharp, 2018, The AAPS Journal.

PBPK Absorption Modeling: Establishing the In Vitro–In Vivo Link—Industry Perspective

Filippos Kesisoglou, Neil Parrott, Xavier Pepin, 2019, The AAPS Journal.

Fifty-Eight Years and Counting: High-Impact Publishing in Computational Pharmaceutical Sciences and Mechanism-Based Modeling.

Shiew-Mei Huang, Filippos Kesisoglou, Johannes G Khinast, 2019, Journal of pharmaceutical sciences.

Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report

Filippos Kesisoglou, Tycho Heimbach, Sandra Suarez-Sharp, 2018, The AAPS Journal.

Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling

Filippos Kesisoglou, Yunhui Wu, F. Kesisoglou, 2008, The AAPS Journal.

Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies.

Filippos Kesisoglou, Neil Parrott, Tycho Heimbach, 2019, Journal of pharmaceutical sciences.

Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid.

Talia Flanagan, Anette Müllertz, Filippos Kesisoglou, 2016, Journal of pharmaceutical sciences.

Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.

Filippos Kesisoglou, Christos Reppas, Jennifer B Dressman, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Utility of PBPK Absorption Modeling to Guide Modified Release Formulation Development of Gaboxadol, a Highly Soluble Compound With Region-Dependent Absorption.

Filippos Kesisoglou, Anand Balakrishnan, Kimberly Manser, 2016, Journal of pharmaceutical sciences.

Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.

Andre Hermans, Filippos Kesisoglou, K. Yee, 2015, Journal of pharmaceutical sciences.

3D printed capsules for quantitative regional absorption studies in the GI tract

Andre Hermans, Filippos Kesisoglou, F. Kesisoglou, 2018, International journal of pharmaceutics.

Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.

Filippos Kesisoglou, Christos Reppas, Jennifer B Dressman, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Nanosizing--oral formulation development and biopharmaceutical evaluation.

Filippos Kesisoglou, F. Kesisoglou, Yunhui Wu, 2007, Advanced drug delivery reviews.

Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate

Filippos Kesisoglou, Binfeng Xia, Nancy G. B. Agrawal, 2015, The AAPS Journal.

Use of Preclinical Dog Studies and Absorption Modeling to Facilitate Late Stage Formulation Bridging for a BCS II Drug Candidate

Filippos Kesisoglou, F. Kesisoglou, 2013, AAPS PharmSciTech.

In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration

Anette Müllertz, Filippos Kesisoglou, Christos Reppas, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Application of Nanoparticles in Oral Delivery of Immediate Release Formulations

Filippos Kesisoglou, F. Kesisoglou, Yunhui Wu, 2007 .

Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.

Filippos Kesisoglou, Shaun Fitzpatrick, S. Fitzpatrick, 2014, Journal of pharmaceutical sciences.

Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.

Filippos Kesisoglou, Christos Reppas, Christian Wagner, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Physiologically Based Absorption Modeling to Impact Biopharmaceutics and Formulation Strategies in Drug Development-Industry Case Studies.

Filippos Kesisoglou, Tycho Heimbach, T. Heimbach, 2016, Journal of pharmaceutical sciences.

Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling

Filippos Kesisoglou, F. Kesisoglou, Yunhui Wu, 2008, The AAPS Journal.

Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.

Wei Xu, Filippos Kesisoglou, Jennifer B Dressman, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.